MedTrace Logo

A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD

NCT03964272 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-03-20

No results posted yet for this study

Summary

The objective of this study is to test the safety and preliminary efficacy of staged bilateral subthalamotomy performed using the ExAblate Transcranial System for the treatment of Parkinson's disease (PD) motor features

Conditions

  • Parkinson Disease
  • Neurologic Manifestations

Interventions

DEVICE

Exablate Bilateral Subthalamotomy

Exablate bilateral treatment for Parkinson's Disease Motor Features

Sponsors & Collaborators

  • InSightec

    lead INDUSTRY

Principal Investigators

  • Raul Martinez, MD · CINAC-Hospital HM Puerta del Sur

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-18
Primary Completion
2023-11-07
Completion
2023-11-07

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03964272 on ClinicalTrials.gov